Out of work and addicted to the anti-anxiety medication Klonopin, Heather Delaney, a licensed practical nurse from Stratford, checked herself into Bridgeport Hospital in 2011 when she could no longer handle withdrawal without medical help.
Acceptance for medical marijuana is growing among people who swear by marijuana's power to relieve their ills. Older people are choosing marijuana for their aches and pains, parents are moving to states where marijuana is legal for children with seizure disorders, even pet owners are using pot to ease their pup's pain. It's currently legal in 28 states with several more on deck.
Just as U.S. Attorney General Jeff Sessions announced he was cracking down on pot, Connecticut’s medical marijuana program announced that it was looking for more dispensaries. The challenges could just be getting started.
This week, Governor Dannel Malloy called for a ban on "bump stocks" -- devices that can make semi-automatic weapons fire like machine guns. Pfizer announced plans to end research into treatments for Parkinson's and Alzheimer's diseases -- and they announced several hundred layoffs including at their facility in Groton.
Pfizer has announced plans to end its research efforts to discover new drugs for Alzheimer's and Parkinson's diseases. The pharmaceutical giant explained its decision, which will entail roughly 300 layoffs, as a move to better position itself "to bring new therapies to patients who need them."
British neuroscientist Joseph Jebelli first set out to study Alzheimer's because of his grandfather, who developed the disease when Jebelli was 12.
In the years that followed, Jebelli watched as his grandfather's memory started to disappear. But Jebelli points out that although a certain amount of memory loss is a natural part of aging, what happened to his grandfather and to other Alzheimer's patients is different.